Divalent ions as mediators of carbonylation in cardiac myosin binding protein C.


Journal

Journal of molecular graphics & modelling
ISSN: 1873-4243
Titre abrégé: J Mol Graph Model
Pays: United States
ID NLM: 9716237

Informations de publication

Date de publication:
11 2023
Historique:
received: 23 05 2023
revised: 12 07 2023
accepted: 27 07 2023
medline: 14 8 2023
pubmed: 4 8 2023
entrez: 3 8 2023
Statut: ppublish

Résumé

The dosing and efficacy of chemotherapeutic drugs can be limited by toxicity caused by off-pathway reactions. One hypothesis for how such toxicity arises is via metal-catalyzed oxidative damage of cardiac myosin binding protein C (cMyBP-C) found in cardiac tissue. Previous research indicates that metal ion mediated reactive oxygen species induce high levels of protein carbonylation, changing the structure and function of this protein. In this work, we use long timescale all-atom molecular dynamics simulations to investigate the ion environment surrounding the C0 and C1 subunits of cMyBP-C responsible for actin binding. We show that divalent cations are co-localized with protein carbonylation-prone amino acid residues and that carbonylation of these residues can lead to site-specific interruption to the actin-cMyBP-C binding.

Identifiants

pubmed: 37536231
pii: S1093-3263(23)00174-2
doi: 10.1016/j.jmgm.2023.108576
pii:
doi:

Substances chimiques

Actins 0
Carrier Proteins 0
Protein C 0
Metals 0
Cardiac Myosins EC 3.6.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108576

Informations de copyright

Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Christina Bergonzo (C)

Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology, the University of Maryland, 9600 Gudelsky Way, Rockville, MD, 20850, USA. Electronic address: christina.bergonzo@nist.gov.

Baikuntha Aryal (B)

Laboratory of Applied Biochemistry, Division of Biotechnology Review and Research III, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.

V Ashutosh Rao (VA)

Laboratory of Applied Biochemistry, Division of Biotechnology Review and Research III, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.

Articles similaires

Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Cerebrospinal Fluid Animals Liver Glymphatic System Spinal Cord

Hemiarthroplasty in young patients.

Hazimah Mahmud, Dong Wang, Andra Topan-Rat et al.
1.00
Humans Male Hemiarthroplasty Middle Aged Aged
Animals Humans Sarcomeres Muscle Proteins Carrier Proteins

Classifications MeSH